Projecting heart failure into bankruptcy in 2012?

American Heart Journal

Volumn 161, Issue 6, 2011, Pages 1007-1011

  Stevenson, Lynne Warner ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; SPIRONOLACTONE;

BETA ADRENERGIC RECEPTOR BLOCKING; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DRUG EFFICACY; HEALTH CARE COST; HEALTH CARE QUALITY; HEART FAILURE; HUMAN; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; REVIEW; SUDDEN DEATH; SURVIVOR; COMORBIDITY; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; MORTALITY; NOTE; UNITED STATES;

COMORBIDITY; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; UNITED STATES;

EID: 79958099646     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.03.020     Document Type: Editorial

References (40)

1. Hunt S. ACC/AHA 2005 guidelines update for diagnosis and management of chronic heart failure in the adult. J Am Coll Cardiol, Circulation 2005. Available at: www.acc.org ; www.americanheart.org.
2. P.G. Shekelle, M.W. Rich, and S.C. Morton Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials J Am Coll Cardiol 41 2003 1529 1538 (Pubitemid 36543372)
3. G.C. Fonarow, N.M. Albert, and A.B. Curtis Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 2010 585 596
4. J.P. Piccini, A.F. Hernandez, and D. Dai Use of cardiac resynchronization therapy in patients hospitalized with heart failure Circulation 118 2008 926 933
5. F.A. Masoudi, E.D. Peterson, and J.L. Anderson Clinical guidelines and performance measures; responsible guidance and accountability J Am Coll Cardiol 56 2010 2081 2083
6. Peterson PN, Rumsfeld JS, Liang L, et al. Treatment and risk in heart failure: gaps in evidence or quality? Circ Cardiovasc Qual Outcomes 3:309-15.
7. G.C. Fonarow, C.W. Yancy, and A.F. Hernandez Potential impact of optimal implementation of evidence-based heart failure therapies on mortality Am Heart J 161 2011 1023 1029
8. G.C. Fonarow, C.W. Yancy, and N.M. Albert Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF Circ Heart Fail 1 2008 98 106
9. S.C. Hammill, M.S. Kremers, and L.W. Stevenson Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure Heart Rhythm 7 2010 1340 1345
10. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121(7):e46-215.
11. L.W. Stevenson, A.S. Hellkamp, and C.V. Leier Changing preferences for survival after hospitalization with advanced heart failure J Am Coll Cardiol 52 2008 1702 1708
12. J.M. Bostwick, and C.L. Sola An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life Psychiatric Clinics of North America 30 2007 677 688 (Pubitemid 47552649)
13. G. Stewart, J.R. Weintraub, and P. Pratibhu Patient expectations from implantable defibrillators to prevent death in heart failure Journal of Cardiac Failure 15 2009 [in press]
14. Lampert R, Hayes DL, Annas GJ, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 7:1008-26.
15. J.P. Curtis, J.J. Luebbert, and Y. Wang Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator JAMA 301 2009 1661 1670
16. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary Heart Rhythm 5 2008 934 955
17. S. Setoguchi, L.W. Stevenson, and S. Schneeweiss Repeated hospitalizations predict mortality in the community population with heart failure Am Heart J 154 2007 260 266 (Pubitemid 47079017)
18. D.S. Lee, P.C. Austin, and J.L. Rouleau Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587 (Pubitemid 37443288)
19. J.B. Braunstein, G.F. Anderson, and G. Gerstenblith Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure J Am Coll Cardiol 42 2003 1226 1233 (Pubitemid 37188347)
20. T.E. Owan, D.O. Hodge, and R.M. Herges Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259 (Pubitemid 44079340)
21. L. Stevenson, and A. Desai Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure J Card Fail 12 2006 407 412 (Pubitemid 46110776)
22. H. Ghanbari, G. Dalloul, and R. Hasan Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials Arch Intern Med 169 2009 1500 1506
23. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
24. I. Goldenberg, A.K. Vyas, and W.J. Hall Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
25. A.E. Epstein, G.N. Kay, and V.J. Plumb Implantable cardioverter- defibrillator prescription in the elderly Heart Rhythm 6 2009 1136 1143
26. S. Setoguchi, A. Nohria, and J.A. Rassen Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure CMAJ 180 2009 611 616
27. W.T. Abraham, W.G. Fisher, and A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853 (Pubitemid 34603028)
28. M.R. Bristow, L.A. Saxon, and J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
29. B. Bozkurt, I. Agoston, and A.A. Knowlton Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines J Am Coll Cardiol 41 2003 211 214 (Pubitemid 36092186)
30. M. Svensson, F. Gustafsson, and S. Galatius How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail 10 2004 297 303 (Pubitemid 39092680)
31. D.N. Juurlink, M.M. Mamdani, and D.S. Lee Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551 (Pubitemid 39025171)
32. A.L. Taylor, S. Ziesche, and C. Yancy Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
33. P.A. Heidenreich, W.R. Lewis, and K.A. LaBresh Hospital performance recognition with the Get With The Guidelines program and mortality for acute myocardial infarction and heart failure Am Heart J 158 2009 546 553
34. D. Gregory, J.E. Udelson, and M.A. Konstam Economic impact of beta blockade in heart failure Am J Med 110 Suppl 7A 2001 74S 80S
35. R. Gupta, W.H. Tang, and J.B. Young Patterns of beta-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic Am Heart J 147 2004 79 83 (Pubitemid 38037401)
36. J.K. Allen, and C.R. Dennison Randomized trials of nursing interventions for secondary prevention in patients with coronary artery disease and heart failure: systematic review J Cardiovasc Nurs 25 2010 207 220
37. S.I. Chaudhry, J.A. Mattera, and J.P. Curtis Telemonitoring in patients with heart failure N Engl J Med 363 2010 2301 2309
38. J.G. Howlett, O.E. Mann, and R. Baillie Heart failure clinics are associated with clinical benefit in both tertiary and community care settings: data from the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) registry Can J Cardiol 25 2009 e306 e311
39. F.A. McAlister, F.M. Lawson, and K.K. Teo A systematic review of randomized trials of disease management programs in heart failure Am J Med 110 2001 378 384 (Pubitemid 32245810)
40. A.M. Clark, L.A. Savard, and D.R. Thompson What is the strength of evidence for heart failure disease-management programs? J Am Coll Cardiol 54 2009 397 401